Discover
ITCI
Intra-Cellular Therapies, Inc.
131.87
undefined x undefined
undefined x undefined
bid
ask
+
131.87
0.00%
07:00 PM
| Ytd | 57.89% | |
| 1y | 97.80% |
day range
52 week range
| Open | Prev Close | Low | High | Mkt Cap | N/A | ||||
| Vol | 0.00 | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | 507.19 |
| Beta | 0.46 | Short Ratio | 1.20 | Inst. Own | 96.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 132.00 |
| Income Statement | |||
| Total Revenue | 199.22M | ||
| Revenues (USD) | 199.22M | ||
| Cost of Revenue | 20.41M | ||
| Gross Profit | 178.82M | ||
| Operating Expenses | 208.02M | ||
| Research and Development Expense | 70.29M | ||
| Selling, General and Administrative Expense | 137.73M | ||
| Operating Income | -29.20M | ||
| Income Tax Expense | -317.00K | ||
| Net Income | -16.89M | ||
| Net Income Common Stock | -16.89M | ||
| Net Income Common Stock (USD) | -16.89M | ||
| Consolidated Income | -16.89M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -17.20M | ||
| Earning Before Interest & Taxes (USD) | -17.20M | ||
| Weighted Average Shares | 106.12M | ||
| Weighted Average Shares Diluted | 106.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 308.70M | ||
| Cash and Equivalents (USD) | 308.70M | ||
| Investments | 694.12M | ||
| Investments Current | 694.12M | ||
| Trade and Non-Trade Receivables | 166.50M | ||
| Current Assets | 1.31B | ||
| Property, Plant & Equipment Net | 14.90M | ||
| Total Assets | 1.37B | ||
| Debt Current | 4.23M | ||
| Total Debt | 16.98M | ||
| Current Liabilities | 205.70M | ||
| Debt Non-Current | 12.75M | ||
| Total Liabilities | 218.45M | ||
| Accumulated Retained Earnings (Deficit) | -1.69B | ||
| Accumulated Other Comprehensive Income | 191.00K | ||
| Shareholders Equity | 1.15B | ||
| Shareholders Equity (USD) | 1.15B | ||
| Assets Non-Current | 59.55M | ||
| Total Debt (USD) | 16.98M | ||
| Inventory | 65.17M | ||
| Liabilities Non-Current | 12.75M | ||
| Trade and Non-Trade Payables | 26.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 109.00K | ||
| Net Cash Flow from Financing | 5.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -157.36M | ||
| Capital Expenditure | 427.00K | ||
| Issuance (Purchase) of Equity Shares | 5.61M | ||
| Net Cash Flow from Investing | -149.89M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -150.32M | ||
| Net Cash Flow from Operations | -13.08M | ||
| Share Based Compensation | 16.35M | ||